Completed
Phase 1 Dose Escalation Study of SN2310 Injectable Emulsion in Patients With Advanced Solid Tumors
NCT00385177
- Conditions
- Breast Diseases, Breast Neoplasms, Colonic Diseases, +22 more
- Locations
-
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
- Sarah Cannon Research Institute Nashville, Tennessee, United States